Estrategia para el diagnóstico de las dislipidemias. Recomendación 2018-Reference-Cited by-同舟云学术

Estrategia para el diagnóstico de las dislipidemias. Recomendación 2018

Published:2019-10 Issue:4 Volume:12 Page:e21-e33
ISSN:1888-4008
Container-title:Revista del Laboratorio Clínico
language:es
Short-container-title:Revista del Laboratorio Clínico

Author:

Candás Estébanez Beatriz,Pocoví Mieras Miguel,Romero Román Carlos,Vella Ramírez Juan Carlos,Esteban Salán Margarita,Castro Castro María José,Rodríguez García Enrique,Arrobas Velilla Teresa,Calmarza Pilar,Puzo Foncillas José

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry

Reference25 articles.

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

2. Lipoproteína (a): factor de riesgo emergente de enfermedad cardiovascular. Sociedad Española de Bioquímica Clínica y Patología Molecular. Comisión de Lipoproteínas y Enfermedades Vasculares;Esteban Salán;Documentos de la SEQC,2013

3. Hyperlipidemia as a risk factor for cardiovascular disease;Nelson;Prim Care,2013

4. New Cholesterol Guidelines for the Management of Atherosclerotic Cardiovascular Disease Risk

5. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);Circulation.,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of treatment with probiotics in the reduction of altered levels of the lipid profile in humans and rats: a systematic review;Proceedings of Scientific Research Universidad Anáhuac. Multidisciplinary Journal of Healthcare;2023-12-31

2. Resistencia a la insulina: sustrato fisiopatológico del síndrome metabólico;Anatomía Digital;2023-09-15

3. Resistencia a la insulina como factor desencadenante de dislipidemia;Salud, Ciencia y Tecnología;2022-12-19